As half of CTNNB1 mutant liver cancer harbors TP53 mutation (SI Appendix, Table S2) (15, 18, –20), we simultaneously activated β-catenin by deleting its exon 3 and inactivated TP53 by knocking it out in mouse liver. The gene discussed is TP53; the disease is liver cancer.